Experienced in Systemic Sclerosis (SSc)

Dr. Dustin Fraidenburg

Intensive Care Medicine
UI Health Lung Health Program
1801 W Taylor St Ste 3C, 
Chicago, IL 
Offers Telehealth
17 Years of Experience

Experienced in Systemic Sclerosis (SSc)
UI Health Lung Health Program
1801 W Taylor St Ste 3C, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dustin Fraidenburg is an Intensive Care Medicine provider in Chicago, Illinois. Dr. Fraidenburg has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Systemic Sclerosis (SSc).

His clinical research consists of co-authoring 33 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Intensive Care Medicine
Licenses
Internal Medicine in IL
Hospital Affiliations
University Of Illinois Hospital And Clinics
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 7 Less Insurance Carriers -

Locations

UI Health Lung Health Program
1801 W Taylor St Ste 3C, Chicago, IL 60612
Call: 312-996-3800
Other Locations
University of Illinois Hospital
1331 W 75th St, Naperville, IL 60540
Call: 866-600-2273

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

33 Total Publications

Thrombomodulin protects against acute vascular and multiorgan injury in Sickle Cell disease.
Thrombomodulin protects against acute vascular and multiorgan injury in Sickle Cell disease.
Journal: JCI insight
Published: December 09, 2025
View All 33 Publications
Similar Doctors
Distinguished in Systemic Sclerosis (SSc)
Dr. James Gagermeier
Intensive Care Medicine
Distinguished in Systemic Sclerosis (SSc)
Dr. James Gagermeier
Intensive Care Medicine

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (7.7 miles away)
888-584-7888
Languages Spoken:
English
See accepted insurances

James Gagermeier is an Intensive Care Medicine provider in Maywood, Illinois. Dr. Gagermeier is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Cystic Fibrosis, Lung Transplant, and Gastrostomy.

Douglas K. Kyle-Hogarth
Advanced in Systemic Sclerosis (SSc)
Dr. Douglas K. Kyle-Hogarth
Pulmonary Medicine | Intensive Care Medicine
Advanced in Systemic Sclerosis (SSc)
Dr. Douglas K. Kyle-Hogarth
Pulmonary Medicine | Intensive Care Medicine

UChicago Medicine Physicians

5758 S Maryland Ave, 
Chicago, IL 
 (7.5 miles away)
773-702-9660
Languages Spoken:
English
See accepted insurances
Offers Telehealth

D. Kyle Hogarth, MD, is an expert in pulmonary diseases. He is also involved with the minimally invasive diagnosis, management, staging and treatment of lung cancer through bronchoscopy. Dr. Hogarth was one of the first doctors in Illinois to work with the superDimension system — an electromagnetic navigation system that uses 3-D imaging technology to detect and biopsy nodules and masses. He was the first physician in the region to utilize the Auris Monarch platform, a robotic bronchoscope that allows deeper access to the lung without surgery. He uses endobronchial ultrasound to biopsy lymph nodes, place stents in cancerous airways, and perform all other minimally invasive techniques to help patients with lung cancer. He sees patients in clinic on Fridays. Dr. Kyle-Hogarth is rated as a Distinguished provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Lung Nodules, Emphysema, Sarcoidosis, Endoscopy, and Advanced Bronchoscopy.

Dean E. Schraufnagel
Advanced in Systemic Sclerosis (SSc)
Dr. Dean E. Schraufnagel
Intensive Care Medicine
Advanced in Systemic Sclerosis (SSc)
Dr. Dean E. Schraufnagel
Intensive Care Medicine
1740 W Taylor St, 
Chicago, IL 
 (1.2 miles away)
866-600-2273
Languages Spoken:
English

Dean Schraufnagel is an Intensive Care Medicine provider in Chicago, Illinois. Dr. Schraufnagel is rated as an Advanced provider by MediFind in the treatment of Systemic Sclerosis (SSc). His top areas of expertise are Nontuberculous Mycobacterial Lung Disease, Systemic Sclerosis (SSc), and Pulmonary Fibrosis.

VIEW MORE SYSTEMIC SCLEROSIS (SSC) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fraidenburg's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Fraidenburg is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Cerebral Hypoxia
    Dr. Fraidenburg is
    Distinguished
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • Advanced
  • Pulmonary Veno-Occlusive Disease
    Dr. Fraidenburg is
    Advanced
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Fraidenburg is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Acute Respiratory Distress Syndrome (ARDS)
    Dr. Fraidenburg is
    Experienced
    . Learn about Acute Respiratory Distress Syndrome (ARDS).
    See more Acute Respiratory Distress Syndrome (ARDS) experts
  • Avian Influenza
    Dr. Fraidenburg is
    Experienced
    . Learn about Avian Influenza.
    See more Avian Influenza experts
  • Cholesterol Pneumonia
    Dr. Fraidenburg is
    Experienced
    . Learn about Cholesterol Pneumonia.
    See more Cholesterol Pneumonia experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Fraidenburg is
    Experienced
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
    Dr. Fraidenburg is
    Experienced
    . Learn about Heart Failure with Preserved Ejection Fraction (HFpEF).
    See more Heart Failure with Preserved Ejection Fraction (HFpEF) experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.